Artigo Revisado por pares

Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations

2016; Wiley; Volume: 170; Issue: 12 Linguagem: Inglês

10.1002/ajmg.a.37940

ISSN

1552-4833

Autores

Patricia Fergelot, Martine van Belzen, Julien Van‐Gils, Alexandra Afenjar, Christine M. Armour, Benoı̂t Arveiler, Lex Beets, Lydie Bürglen, Tiffany Busa, Marie Collet, Julie Deforges, Bert B.A. de Vries, Elena Garrido, Nathalie Dorison, Juliette Dupont, Christine Francannet, Sixto García‐Miñaúr, Elisabeth Gabau Vila, Samuel Gebré‐Medhin, Blanca Gener Querol, David Geneviève, Marion Gérard, Cristina Giovanna Gervasini, Alice Goldenberg, Dragana Josifova, Katherine Lachlan, Saskia M. Maas, Bruno Maranda, Jukka S. Moilanen, Ann Nordgren, P. Parent, Julia Rankin, William Reardon, Marlène Rio, J. Roume, Adam Shaw, Robert Śmigiel, A Sojo, Benjamin D. Solomon, Agnieszka Stembalska, Constance T.R.M. Stumpel, F J Ortega Suárez, Paulien A. Terhal, Simon Thomas, Renaud Touraine, Alain Verloès, Catherine Vincent‐Delorme, Josephine Wincent, Dorien J.M. Peters, Oliver Bartsch, Lidia Larizza, Didier Lacombe, Raoul C. M. Hennekam,

Tópico(s)

Chromosomal and Genetic Variations

Resumo

Rubinstein–Taybi syndrome (RSTS) is a developmental disorder characterized by a typical face and distal limbs abnormalities, intellectual disability, and a vast number of other features. Two genes are known to cause RSTS, CREBBP in 60% and EP300 in 8–10% of clinically diagnosed cases. Both paralogs act in chromatin remodeling and encode for transcriptional co‐activators interacting with >400 proteins. Up to now 26 individuals with an EP300 mutation have been published. Here, we describe the phenotype and genotype of 42 unpublished RSTS patients carrying EP300 mutations and intragenic deletions and offer an update on another 10 patients. We compare the data to 308 individuals with CREBBP mutations. We demonstrate that EP300 mutations cause a phenotype that typically resembles the classical RSTS phenotype due to CREBBP mutations to a great extent, although most facial signs are less marked with the exception of a low‐hanging columella. The limb anomalies are more similar to those in CREBBP mutated individuals except for angulation of thumbs and halluces which is very uncommon in EP300 mutated individuals. The intellectual disability is variable but typically less marked whereas the microcephaly is more common. All types of mutations occur but truncating mutations and small rearrangements are most common (86%). Missense mutations in the HAT domain are associated with a classical RSTS phenotype but otherwise no genotype–phenotype correlation is detected. Pre‐eclampsia occurs in 12/52 mothers of EP300 mutated individuals versus in 2/59 mothers of CREBBP mutated individuals, making pregnancy with an EP300 mutated fetus the strongest known predictor for pre‐eclampsia. © 2016 Wiley Periodicals, Inc.

Referência(s)